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While much progress has been made in identifying the brain regions and neurochemical
systems involved in the cognitive processes disrupted in mental illnesses, to date, the
level of detail at which neurobiologists can describe the chain of events giving rise to
cognitive functions is very rudimentary. Much of the intense interest in understanding
cognitive functions is motivated by the hope that it might be possible to understand
these complex functions at the level of neurons and neural circuits. Here, we review
the current state of the literature regarding how modulations in catecholamine levels
within the prefrontal cortex (PFC) alter the neuronal and behavioral correlates of cognitive
functions, particularly attention and working memory.
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INTRODUCTION
Attention, working memory, impulse control, and other “top-
down” cognitive functions have long been known to depend
on the prefrontal cortex (PFC) (Ghent et al., 1962; Chao and
Knight, 1998; D’Esposito and Postle, 1999). Many of these cogni-
tive functions are disrupted in mental disorders such as attention
deficit hyperactivity disorder (ADHD), Parkinson’s disease, and
schizophrenia. Studies in human and non-human primates have
implicated prefrontal catecholamines in control of cognitive func-
tions. Notably, drugs altering catecholamine signaling have been
used to treat the symptoms of some of these mental illnesses.
Consequently, an imbalance in prefrontal catecholamines has
long been a suspected cause of the cognitive component of these
mental illnesses. Our goal is to review studies examining the
contribution of prefrontal catecholamines to cognitive tasks and
their dysfunction. Due to known differences between rodents and
primates (Berger et al., 1991), this review will be focused on stud-
ies in human and non-human primates. Among catecholamines,
the main focus will be on dopamine (DA), however the role of
norepinephrine (NE) will also be briefly addressed. We survey
the evidence implicating prefrontal catecholamines as the neu-
rochemical mediator of the neural and behavioral signatures of
attention and working memory, and link these neurobiological
findings to the etiology and treatment of cognitive impairments
in mental disorders.
EFFECTS OF DAWITHIN PFC
The importance of prefrontal DA in delayed-response tasks was
established very early on (Brozoski et al., 1979), and much work
has since gone into unraveling the details of this dependence (see
Table 1). The PFC receives DA-ergic projections from both the
ventral tegmental area (VTA) and the substantia nigra (Porrino
and Goldman-Rakic, 1982; Levitt et al., 1984; Goldman-Rakic
et al., 1992). DA neurons in the VTA and substantia nigra exhibit
both tonic activity, and phasic responses associated with the
expectation of reward (Schultz et al., 1993) or reward prediction
errors (Schultz, 1998).While DA neurons are activated by the spa-
tial cue in the working memory tasks discussed below (since it
signals the availability of a reward in the near future), this acti-
vation differs from that observed in PFC itself in that it does not
reflect the cue position, nor does it continue throughout the delay
period (Schultz et al., 1993). Therefore, the incoming DA-ergic
input to PFC does not directly encode the remembered stimulus,
but could potentially serve to “tune” the prefrontal network for
optimal activity.
In order to understand the effects of prefrontal DA release on
neural activity, first let us consider DA receptors and the anatomy
of DA-ergic terminals in PFC. DA receptors are G-protein-
coupled receptors, modulating neuronal activity via intracellular
signaling cascades rather than directly inducing either excitatory
or inhibitory postsynaptic currents (Yang and Seamans, 1996;
Lachowicz and Sibley, 1997; Missale et al., 1998). The five types
of DA receptor are commonly divided into two classes: the D1
family (comprised of D1 and D5 receptors) and the D2 family
(D2, D3, and D4 receptors) (Missale et al., 1998; Seamans and
Yang, 2004). Expression for D1 receptors (D1Rs) is enriched in
the PFC of both primates and rodents, suggesting an important
role in specifically prefrontal circuit functions (Lidow et al., 1991;
Goldman-Rakic et al., 1992). Within PFC, D1Rs are expressed
in both superficial and deep cortical layers, while expression of
the less abundant D2Rs is limited to the infragranular layers
(Lidow et al., 1991). Although this bilaminar distribution pattern
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Table 1 | Studies examining the contribution of prefrontal catecholamines to the behavioral and neural correlates of working memory in
non-human primates.
Study Pharmacological
agent
Method of
administration
Brain area Behavioral and neuronal effects
N
on
-s
pe
ci
fic
D
A
Schneider and Kovelowski, 1990;
Schneider and Roeltgen, 1993;
Fernandez-Ruiz et al., 1995; Slovin
et al., 1999; Decamp and Schneider,
2004
MPTP Systemic Delayed spatial response, delayed match
to sample, and attentional deficits; no
motor impairments
Fernández-Ruiz et al., 1999 MPTP, L-dopa Systemic L-dopa helps rescue the spatial working
memory deficits
Brozoski et al., 1979 6-OHDA: ablated DA
projections to PFC
Pressure
injection, in vivo
PFC DA depletion impaired performance on
delayed response task; reversed by DA
agonist
D
1R
s
Cai and Arnsten, 1997 D1R agonist Systemic Low doses improved aged monkey WM
performance; higher doses impaired
(effects disrupted by D1R antagonist)
Noudoost and Moore, 2011b D1R antagonist Pressure
injection, in vivo
FEF Increased saccadic target selection in
free-choice task
Sawaguchi and Goldman-Rakic,
1991, 1994
D1R antagonist Pressure
injection, in vivo
dIPFC Increased errors and increased latency on
MGS task
Arnsten et al., 1994 D1R antagonist Systemic Antagonist impaired memory performance
of young but not old monkeys
Arnsten et al., 1994 Partial D1R agonist Systemic Improved memory performance in old or
artificially depleted, but not young animals
(effect of D1R agonist blocked by
antagonist)
Puig and Miller, 2012 D1R antagonist Pressure
injection, in vivo
dIPFC, vIPFC D1R antagonist impairs learning
stim-response association, esp in vIPFC
Schneider et al., 1994a,b D1R antagonist Systemic Potent D1R agonist can ameliorate
MPTP-induced spatial memory impairment
Sawaguchi et al., 1988, 1990a DA Iontophoresis dIPFC Increased activity in delayed response task
Sawaguchi et al., 1990b D1R antagonist Iontophoresis dIPFC Decreased activity in delayed response
task, decreased SNR
Vijayraghavan et al., 2007 D1R antagonist Iontophoresis dIPFC Dose-dependent enhancement or
suppression of delay selectivity during
MGS
Williams and Goldman-Rakic, 1995 D1R antagonist Iontophoresis dIPFC Reduced D1R signaling improves delay
selectivity during MGS
Dose-dependent, effect reversed by D1R
agonist
Jacob et al., 2013 DA Iontophoresis dIPFC Putative interneurons: DA suppressed
activity but preserved SNR
Putative pyramidal: DA enhanced activiity,
increased SNR, reduced variability
Puig and Miller, 2012 D1R antagonist Pressure
injection, in vivo
dIPFC, vIPFC Increased low-frequency (alpha and beta)
LFP power during learned association task
Castner and Williams, 2007 D1R agonist,
antagonist
Iontophoresis dIPFC Greater D1R signaling reduces
cross-correlogram peak (ie, decreased
senstivity to inputs)
González-Burgos et al., 2002;
Gonzalez-Burgos et al., 2005
D1R agonist Slice dIPFC Reduced EPSP magnitude in GABAergic
interneurons
Henze et al., 2000 DA Slice dIPFC Increased layer 3 pyramidal excitability
(effect blocked by D1R antagonist but not
D2R antagonist)
Noudoost and Moore, 2011b D1R antagonist Pressure
injection, in vivo
FEF Increased V4 response magnitude and
selectivity; decreased variability
(Continued)
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Table 1 | Continued
Study Pharmacological
agent
Method of
administration
Brain area Behavioral and neuronal effects
D
2R
s
Arnsten et al., 1995 D2R agonist Systemic Impairs delayed response performance in
young, but not old, monkeys
Noudoost and Moore, 2011a,b,c D2R agonist Pressure
injection, in vivo
FEF Increased saccadic target selection in
free-choice task
Williams and Goldman-Rakic, 1995 19932R antagonist lontophoresis dIPFC General suppression of activity; no
selective effect on delay period
Sawaguchi et al., 1990b D2R antagonist lontophoresis dIPFC No effect on activity in delayed response
task
Wang et al., 2004 D2R antagonist lontophoresis dIPFC Suppressed motor but not memory or cue
activity in MGS task
Wang et al., 2004 D2R agonist lontophoresis dIPFC Enhanced motor but not memory or cue
activity in MGS task
Noudoost and Moore, 2011b D2R agonist Pressure
injection, in vivo
FEF No effect on V4 responses
A
lp
ha
-2
A
Li and Mei, 1994 Alpha-1 and 2 and
beta antagonists
Pressure
injection, in vivo
dIPFC Alpha-2 antagonist (but not alpha1 or beta)
impaired spatial delayed response of
young monkeys
Arnsten et al., 1988 Alpha-2A agonist Systemic Alpha-2A agonist improved performance
of aged monkeys on a spatial delayed
response task
Rämä et al., 1996 Alpha-2 agonist Systemic Alpha-2A and 2B agonist improved delayed
response performance of aged monkeys
Arnsten and Contant, 1992 Alpha-2A agonist Systemic Alpha-2A agonist prevented irrelevant
distractors from disrupting delayed
response in aged monkeys
O’Neill et al., 2000 Alpha-2A agonist Systemic Alpha-2A agonist improved performance
of aged monkeys for delayed
match-to-sample, single target tracking,
and two-target tracking with distractors
Arnsten and Cai, 1993 Alpha-2 agonist,
antagonist
Systemic Low doses of alpha-2 antagonist
yohimbine improved WM in a subset of
aged monkeys: effect blocked by
postsynaptic antagonist, thought to result
indirectly from increased NE release
Agonist improved performance in aged
animals, also blocked by postsynaptic
antagonists
Beneficial effects of agonist and
antagonist were additive in young, but not
aged, monkeys
Arnsten and Goldman-Rakic, 1985 Alpha-2A agonist Systemic Alpha-2A agonist partially rescues
aging-related impairments in cognitive
performance
Avery et al., 2000 Systemic Alpha-2A agonist improved WM
performance and increased rCBF in dlPFC
Sawaguchi, 1998 Alpha-1 and 2 and
beta antagonists
lontophoresis d1PFC Alpha-2 antagonist (but not alpha1 or beta)
decreased activity and tuning of PFC
neurons in MGS task
Cai et al., 1993 Alpha-2 agonist, DA
and NE depletion
Systemic Chronic catecholamine depletion impaired
delayed response, restored by alpha-2
agonist
Wang et al., 2007 Alpha-2A agonist lontophoresis d1PFC Low dose of alpha-2A agonist enhanced
delay activit during working memory; high
dose suppressed it
(Continued)
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Table 1 | Continued
Study Pharmacological
agent
Method of
administration
Brain area Behavioral and neuronal effects
Li et al., 1999 Alpha-2 agonist,
antagonist
Systemic and
iontophoresis
dIPFC Alpha-2 agonist enhanced and antagonist
suppressed WM-related activity in PFC
Studies are divided by neuromodulator (dopamine or norepinephrine) and specific receptor (D1R, D2R, alpha-2A) where applicable. Abbreviations: MPTP, 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine, which kills dopaminergic neurons in the substantia nigra; 5-OHDA, 5-hydroxydopamine, which selectively kills dopaminergic
and noradrenergic neurons; FEF, Frontal Eye Field; dlPFC, dorsolateral prefrontal cortex; vlPFC, ventrolateral prefrontal cortex; SNR, signal-to-noise ratio; MGS,
memory-guided saccade.
is evident at birth, layer three undergoes a dramatic post-natal
increase in the density of DA innervation, which is then subject to
layer-specific remodeling and decreases in DA axon density dur-
ing adolescence (Lewis and Harris, 1991; Rosenberg and Lewis,
1995; Lewis, 1997); during this period performance on delayed
response tasks improves and becomes more dependent on the
PFC (Alexander and Goldman, 1978). Goldman-Rakic and col-
leagues used immunohistological staining, Golgi impregnation
and electron microscopy to examine DA-ergic synapses in the
PFC. They found that DA-ergic boutons were part of synap-
tic triads, in which the DA-positive bouton formed a symmetric
synapse, while an unlabeled asymmetric synapse (of the type asso-
ciated with excitatory inputs) contacted the same dendritic spine
(Figure 1A). Many of the postsynaptic neurons appear to be pyra-
midal cells. However, targets of DA-ergic projections include both
pyramidal cells and fast-spiking interneurons (Goldman-Rakic
et al., 1989; Sesack et al., 1995, 1998). D1Rs can also be located
outside of synapses (Smiley et al., 1994), suggesting at least some
slow timecourse effects as DA diffuses to these more remote sites
of action. Some DA axonal varicosities also appear to be localized
outside of synaptic specializations (Smiley and Goldman-Rakic,
1993), and may contribute to extrasynaptic “volume transmis-
sion” effects (Zoli et al., 1998). This anatomy seems conducive
to dopamine playing a modulatory role, regulating the efficacy or
strength of prefrontal signals originating elsewhere.
The role of dopamine in modulating glutamatergic activity,
suggested by the presence of synaptic triads, has been directly
tested in slices using dual whole-cell patch clamp recordings,
examining the effect of DA application on synaptic transmis-
sion between neurons. These experiments revealed that DA
reduces the reliability of excitatory neurotransmission by reduc-
ing the probability of glutamate release presynaptically (Gao
et al., 2001). Consistent with this finding, the consequences of
this reduced reliability of synaptic transmission can be read
out in the synchronous activity of neighboring prefrontal neu-
rons in vivo (Figure 1B): iontophoretic application of a D1R
antagonist introduces a peak in the cross-correlogram between
prefrontal pyramidal neurons, as the reliability of transmission
from mutual inputs increases (Castner and Williams, 2007).
Conversely, iontophoretic application of a D1R agonist decreases
synaptic efficacy, disrupting common excitatory input and elimi-
nate existing cross-correlogram peaks for neighboring prefrontal
neurons. Interestingly, DA may have different direct effects
on excitatory and inhibitory neurons within PFC (Gao and
Goldman-Rakic, 2003; Jacob et al., 2013). Using iontophoresis to
examine the effects of DA on prefrontal visual responses during
a visual detection task, Jacob and colleagues found two distinct
types of DA-ergic modulation (Jacob et al., 2013) One group of
PFC neurons, which included all the modulated narrow-spiking,
putatively inhibitory neurons, was inhibited by DA; these showed
short onset latency of DA effects (∼10ms), with no change in
signal-to-noise ratio (SNR) or inter-trial variability. A second set
of prefrontal neurons was excited by DA application, display-
ing an increase in SNR and decrease in inter-trial variability;
this effect was slower (∼200ms) and observed only in broad-
spiking, putatively pyramidal neurons. These direct effects of DA
on the excitability of individual neurons of different types will
then interact at the population level—for example, the activity of
inhibitory neurons helps shape the tuning of excitatory neurons
during working memory (Rao et al., 2000; Constantinidis et al.,
2002).
In addition to modulating neural activity within PFC, DA also
alters activity-dependent plasticity (Gurden et al., 2000; Pawlak
and Kerr, 2008; Zhang et al., 2009). Such plasticity has long been
the focus of study in relation to addiction; however, these changes
may also play a more general role in associative learning. Recent
work in rodent PFC suggests that both D1R and D2R signaling
contribute to changes in plasticity, with D2R actions on inhibitory
interneurons gating potentiation, and D1Rs on postsynaptic neu-
rons controlling the size of the temporal window during which
coincident spikes induce potentiation (Xu and Yao, 2010). These
effects of DA on plasticity, and the known firing of DA inputs
to PFC in response to prediction errors, suggest an influence
of prefrontal DA on learning, and indeed a recent study reveals
just such an effect (Puig and Miller, 2012). Local injection of a
D1R antagonist into ventrolateral prefrontal cortex (vlPFC) was
found to impair monkeys’ acquisition of novel visuomotor asso-
ciations, without impairing performance on familiar associations.
This behavioral effect was accompanied by changes in prefrontal
activity, again observed for novel but not familiar cues: selec-
tivity of individual neurons for the upcoming motor response
decreased, while synchronous discharge and low-frequency LFP
power increased. Human experiments have also linked phasic
activity in midbrain DA nuclei and PFC with context-dependent
working memory performance (D’Ardenne et al., 2012). Thus,
phasic discharge of prefrontal DA inputs may be particularly
important during the learning of novel associations and tasks, or
contextual switching between rules.
Williams and Goldman-Rakic used iontophoresis in a behav-
ing monkey to extend these findings on the cellular effects
of DA to its role in prefrontal circuits during a spatial
working memory task (Williams and Goldman-Rakic, 1995).
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FIGURE 1 | DA modulates the efficacy of synaptic connections within
PFC. (A) Cartoon illustrates a characteristic “synaptic triad” in monkey PFC:
the same spine (S) is postsynaptic to both a DA-positive axon (DA) and a
non-immunoreactive axon terminal (non-DA). The synapse of the DA axon is
symmetric, while the non-DA axon forms an asymmetric synapse. Based on
electron micrography and immunostaining of synaptic connections in layer II
of monkey PFC (from Goldman-Rakic et al., 1989). (B) D1R signaling alters
synaptic efficacy, a measured by changes in the synchronous firing of pairs of
PFC neurons. Castner and Williams (2007) simultaneously recorded from
pairs of neurons in monkey PFC before and after delivering a D1R agonist or
antagonist using in vivo iontophoresis. Cross-correlograms depict the number
of spikes occurring at a particular time-lag relative to spikes of the other
neuron in the pair: a peak at 0ms indicates simultaneous firing due to
common input. The top pair of PFC neurons exhibited a 0ms peak prior to
drug infusion (gray): application of a D1R agonist eliminated this peak (red),
presumably by disrupting the efficacy of common input. In the bottom plot,
the neurons did not show evidence of common input during the control
recordings (gray), but a peak emerged following application of a D1R
antagonist (red), reflecting stronger or more reliable excitation from their
common inputs. (C) Effects of D1R agonists and antagonists on working
memory performance will depend on initial levels of PFC DA. Gray curves
illustrate working memory performance as a function of PFC DA level:
performance is greatest at an intermediate level, with insufficient or
excessive DA leading to impaired performance. Basal DA levels (illustrated by
the dashed lines) are usually tuned for optimal performance (middle curve),
but are sub-optimal in aged animals (back curve), and above optimal in the
case of stress (front curve). D1R agonists (red arrows) and antagonists (blue
arrows) effect working memory performance differently based on initial DA
levels: if initial DA levels are supra-optimal, as in stress, then D1R antagonists
will move DA signaling toward the optimal level, improving performance,
while agonists will further impair performance. If initial DA levels are below
optimal, as in aged animals, then D1R agonists will increase DA signaling
back toward optimal levels, improving performance; D1R antagonists will
move DA levels further from optimal, impairing performance.
Iontophoretic application of a D1R antagonist during spatial
working memory selectively enhances delay-period activity rep-
resenting the remembered location. The effect is dose-dependent,
with enhanced delay activity for an intermediate level of D1R
antagonist, but suppression of both delay and visual activity in
the same cell when a greater concentration of the drug is applied.
This “inverted-U” dose-dependency, in which an intermediate
level of DA signaling produces more selective memory activity,
has also been observed for a D1R agonist: low doses suppressed
only responses to non-preferred locations, enhancing the spatial
tuning of delay activity, while higher doses suppressed activ-
ity altogether (Vijayraghavan et al., 2007). How to reconcile the
apparently contradictory findings that a low dose of either a
D1R agonist (Vijayraghavan et al., 2007) or a D1R antagonist
(Williams and Goldman-Rakic, 1995) improves the selectivity of
PFC delay activity? Presumably the answer lies in the original level
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of DA-ergic tone in the PFC neurons being studied (Figure 1C),
although it remains unclear why these studies would have a sys-
tematic difference in baseline prefrontal DA-ergic stimulation.
The known elevation of prefrontal DA by stress (Thierry et al.,
1976; Roth et al., 1988; Abercrombie et al., 1989) further raises
questions as to how the stresses affecting laboratory animals may
impact their baseline DA-ergic tone, and thus the effects of phar-
macological agents. Also note that the basis for improved delay
selectivity appears to differ for the two agents: D1R antagonists
may improve tuning by increasing the level of delay firing for the
preferred location, while the D1R agonist selectively reduces firing
for the non-preferred cue locations.
Several biologically-plausible neurocomputational models
have been developed to incorporate DA or NE-ergic modulation
of prefrontal activity (Servan-Schreiber et al., 1998; Durstewitz
et al., 2000; Brunel and Wang, 2001; Chadderdon and Sporns,
2006; Eckhoff et al., 2009; Avery et al., 2013). One such model
(Chadderdon and Sporns, 2006) of task-oriented behavioral
selection incorporates such disparate brain regions as early visual
areas, inferotemporal cortex, PFC, basal ganglia, and anterior cin-
gulate cortex. At the heart of this model is amechanism that simu-
lates exogenously induced changes in prefrontal DA release, which
is thought to underlie the updating and maintenance functions of
working memory. More recently, Avery et al. (2013) constructed a
model of PFC designed to capture the effects of signaling through
both DA (D1) and NE (alpha-2A and alpha-1) receptors. Both
of these models were able to reproduce the “inverted-U” effect
of catecholamine signaling, with impaired working memory rep-
resentations when levels were too high or too low. The former
model incorporated changes in prefrontal DA levels over the
course of a delayed match to sample task, using these changes to
switch the prefrontal network between states of updating based
on current inputs vs. maintaining previous inputs, while the latter
instead examined the effects of tonic DA and NE tone on network
behavior. The extent to which fluctuations in PFC DA levels dur-
ing different task epochs occur or contribute to task performance
remains experimentally unproven.
The effect of DA on the activity of prefrontal neurons is com-
plicated, involving multiple mechanisms of direct and indirect
action through D1Rs and D2Rs, affecting presynaptic release,
NMDA, GABA, AMPA, Na+, Ca2+, and K+ currents, among
others (Seamans and Yang, 2004). Various studies have reported
either primarily inhibitory (e.g., Pirot et al., 1992), excitatory
(e.g., Henze et al., 2000), or heterogenous (Jacob et al., 2013)
effects of DA on PFC neurons. The main points we wish to
emphasize here are that DA acts as a neuromodulator, altering the
efficacy of synaptic input to prefrontal neurons, and that there is
some optimal level of DA-ergic stimulation for a neuron to expe-
rience, with greater or lesser DA signaling leading to an erosion of
task related activity.
DOPAMINE, REWARD, AND VISUAL ATTENTION
Given the known firing of prefrontal DA afferents in response to
reward expectation (Schultz, 2013), and the ability of expected
reward to modulate responses throughout the brain, we cannot
discuss the role of DA in prefrontal control of cognitive functions
without considering the effects of reward and to what extent they
can be separated from the other roles of prefrontal DA signal-
ing. In the following sections we first discuss the difficulties in
parsing the behavioral effects and neural signatures of attention
and reward. We review the known role of both prefrontal DA and
reward in modulating responses in visual cortex, and the evidence
for and against prefrontal neurons receiving DA input themselves
representing reward value. The evidence suggests that prefrontal
DA contributes to both representations of target value and to the
behavioral and neural signatures of attention, although further
studies will be needed to determine if DA’s roles in these processes
are dissociable.
DISSOCIATING NEURAL SIGNATURES OF ATTENTION AND REWARD
DA release is associated with reward cues or expectation (Schultz,
2002). The involvement of DA signaling in both attention and
reward raises the question of how these mechanisms overlap or
diverge. Indeed, many behavioral tasks manipulate attention or
reward in such a way that these two properties cannot truly be
distinguished from one another (Maunsell, 2004). Consider a typ-
ical study seeking to identify a neural correlate of reward size
(Figure 2A). One stimulus is placed within the neuron’s response
field (RF), a second outside it; the relative size of the reward
associated with the two locations is then varied, either in blocks
or from trial to trial based on some cue. A neuron that dis-
plays greater activity when the high-reward stimulus appears in
its RF is typically reported as encoding reward expectation or
value. The same logic applies to reward probability, although
this manipulation must be done in blocks. Now consider a typ-
ical “attention” task: multiple stimuli appear onscreen, and one
of them must be monitored for a behavioral response—again,
the selected location may be held constant over a block of tri-
als or varied from trial to trial based on a cue. Sometimes the
task occurs only or more frequently at the cued stimulus—in
other cases the animal is explicitly trained not to respond to
changes at the uncued location; in either version of the atten-
tion task, reward is exclusively or predominantly associated with
the stimulus at the attended location, and yet in these studies
a difference in firing rate is attributed to the locus of atten-
tion rather than an expected reward. Conversely, the “reward”
activity we described in the previous experimental design could
be attributed to attentional modulation, given that on a behav-
ioral level the expectation of a reward attracts attention (Posner,
1980). Importantly, many areas reflecting attentional modula-
tion in their neural activity also exhibit reward-dependent activity
(Figure 2B). A recent study of the effects of reward on activity
in primary visual cortex showed that the strength of reward-size
modulation across cells was strongly correlated with their mod-
ulation by attention, suggesting that the neural sources of these
effects may be overlapping, if not identical (Staˇnis¸or et al., 2013,
discussed further in the next section). Since this critique origi-
nally appeared a decade ago, many studies that experimentally
manipulate reward values acknowledge the potential confound,
or even explicitly attribute their findings to attention (Kennerley
andWallis, 2009), but few attempt to dissociate the two processes.
Even studies using paradigms designed to differentiate repre-
sentations of reward from general behavioral salience (Leathers
and Olson, 2012) have proven controversial (Leathers and Olson,
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FIGURE 2 | Interactions between attention and reward. (A) A
schematic illustration of typical tasks used to study reward and attention,
and how the differences in potential reward and neural activity are similar
between the two paradigms. Consider two studies conducted in V1
(Staˇnis¸or et al., 2013 and McAdams and Reid, 2005). To study the effect
of reward size in the Staˇnis¸or task (schematically illustrated in the top
panel), two potential targets appear, with colors indicating different
reward values. Neural activity recorded at this point in the task reflects
the relative value of the target in the RF (higher activity when the RF
target offered a greater reward than the non-RF target); a subsequent
cue instructs the monkey which target to saccade to. In the McAdams
and Reid attentional paradigm (bottom panel), a cue indicates which of
two stimuli should be monitored for a change, which instructs an eye
movement response to a separate location. Changes at the uncued
location must be ignored, and will never lead to rewards. Neural activity
is higher when the stimulus in the RF is cued. In both cases higher
expected reward value for the stimulus in the RF is associated with
greater neural activity. (B) An overview of brain areas in which neural
activity reflecting both attentional modulation and reward value has been
reported. Only a single study is cited for each area; reward studies are in
gray, attention studies in black. Dotted outlines represent structures not
located on the cortical surface, either within sulci or deeper within the
brain. Abbreviations: PMC, premotor cortex; vlPFC, ventrolateral prefrontal
cortex; dlPFC, dorsolateral prefrontal cortex; SC, superior colliculus; BG,
basal ganglia; LIP, lateral intraparietal area; SEF, supplementary eye field;
ACC, anterior cingulate cortex; FEF, frontal eye field.
2013; Newsome et al., 2013), or generated results that suggest
reward cues can drive attentional allocation in ways that prove
detrimental to task performance (Peck et al., 2009).
MODULATION OF VISUAL REPRESENTATIONS BY PFC DA AND
REWARD
Although many studies have examined the effect of DA-ergic
agents on prefrontal activity, and prefrontal activity has long been
believed to modulate responses in visual cortex during atten-
tion and working memory, until recently no one had directly
examined the effect of locally manipulating prefrontal DA sig-
naling on visual responses in other cortical areas. Noudoost and
Moore (2011b) examined the long-range effects of altering pre-
frontal DA signaling on visual responses in extrastriate area V4.
V4, like much of visual cortex, receives direct projections from
the Frontal Eye Field (FEF) part of the PFC, an area strongly
implicated in controlling spatial attention (Moore and Fallah,
2004; Armstrong et al., 2009; Clark et al., 2012), and it is believed
that these projections may be the source of the changes in activ-
ity observed in V4 during the deployment of covert attention
(Moore and Armstrong, 2003; Awh et al., 2006; Noudoost et al.,
2010, 2014; Squire et al., 2013; Clark et al., 2014). Noudoost
and Moore examined the effects of manipulating either D1Rs
or D2Rs on V4 visual responses during a passive fixation task,
and their effect on saccadic target selection in a free-choice task
(Noudoost and Moore, 2011a,b). While both D1R and D2R
manipulations increased the monkey’s tendency to choose the
saccade target in the affected region of space, biasing saccadic tar-
get selection, only D1Rs had an impact on V4 visual responses.
Local injection of a D1R antagonist into the FEF enhanced the
strength of visual signals in V4: response magnitude increased,
orientation selectivity was enhanced, and trial-to-trial variabil-
ity decreased (Figure 3). All of these changes are also observed
in V4 when covert spatial attention is directed to the V4 neu-
ron’s RF (Moran and Desimone, 1985; McAdams and Maunsell,
2000; Reynolds et al., 2000; Mitchell et al., 2007). The reason
for the differing effects of FEF D1R and D2R manipulations on
V4 activity, but common effects on target selection, may lie in
the patterns of receptor expression within the FEF. D1Rs are
expressed in both the supragranular layers, which project to V4,
and infragranular layers, which contain neurons projecting to
motor areas such as the superior colliculus. In contrast, D2Rs
are primarily expressed in the infragranular layers. This pattern
of expression could account for both receptors influencing tar-
get selection, while only D1Rs alter V4 responses (Noudoost and
Moore, 2011c).
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FIGURE 3 | The effects of PFC DA on visual cortical activity.
Manipulating D1R-mediated FEF activity enhances visual representations
in area V4. Noudoost and Moore (2011b) infused a D1R antagonist into
the FEF while recording from V4 neurons with RFs either overlapping or
not overlapping the area of space represented at the site of drug
infusion; the visual responses of the same V4 neurons were recorded
before and after infusion of drugs into the FEF. FEF RF center was
estimated based on the endpoints of microstimulation-evoked saccades.
FEF D1R manipulation caused an increase in orientation selectivity,
increase in response magnitude, and decrease in response variability at
overlapping V4 sites (orange bars); no effect was seen for
non-overlapping V4 sites (green), or saline infusions (gray). These
changes in V4 responses with FEF D1R manipulation mimic those seen
during covert attention. ∗p < 0.05.
Neurophysiological experiments in V1 have provided a direct
comparison of the effects of attention and reward on visual corti-
cal responses (Staˇnis¸or et al., 2013). Visual responses were shown
to be modulated by the relative reward value of the RF stimulus;
moreover, the magnitude of this modulation was strongly corre-
lated with the strength of atttentional modulation during a later
time window in the same task, and the onset latencies of the two
effects were indistinguishable. Like attentional modulation, the
neural effects of reward value were dramatically enhanced in the
presence of a second stimulus. Human fMRI experiments have
also demonstrated a D1R-dependent reward modulation of visual
cortical activity (Arsenault et al., 2013). These effects of reward
on visual cortex may not be attributable to the PFC—they could
result from a bottom-up influence of DA-ergic changes in LGN
signaling (Zhao et al., 2002), or via direct DA release from mid-
brain projections (Lewis et al., 1987). However, several aspects of
the findings argue in favor of a prefrontal origin to these effects:
the strong correlation with attention in the Staˇnis¸or case, the pres-
ence of this modulation even in trials without a visual stimulus in
the Arsenault paper, the lower density of DA-ergic projections to
visual cortex (Berger et al., 1988), and the proven ability of DA-
ergic PFC activity to modulate representations in visual cortex
(Noudoost and Moore, 2011b), make PFC a likely source of this
reward-induced modulation.
REPRESENTATION OF REWARD VALUE BY PFC NEURONS AND THE
ROLE OF DA IN THIS REPRESENTATION
Multiple studies have looked for representations of reward value
in PFC. Leon and Shadlen (1999) examined the effect of cen-
trally cued reward size on FEF and dlPFC responses during a
memory-guided saccade task. They found an effect on reward
size on responses in dlPFC, but not FEF; this dlPFC reward-
size dependent activity continued throughout the delay period.
Interestingly, the presence of reward-size information in dlPFC
responses was dependent on the simultaneous maintenance of
a spatial memory: in a variant of the task in which the reward
cue appeared before the spatial cue, no reward size informa-
tion was present until after the subsequent spatial cue appeared.
However, findings by Ding and Hikosaka suggest that the FEF
will also represent reward size information under certain condi-
tions: specifically when the reward is tied to a particular location
(Ding and Hikosaka, 2006). Using an asymmetrically rewarded
memory-guided saccade paradigm, in which the relative value
of the two target locations varied between blocks of trials, they
found that about 1/3 of FEF neurons were selective for the loca-
tion of the larger reward during the cue period. This may reflect
the stronger retinotopic organization of the FEF in comparison
to dlPFC (Suzuki and Azuma, 1983; Bruce et al., 1985; Funahashi
et al., 1989). Interestingly, this reward modulation did not per-
sist into the delay period—precisely the time in which the dlPFC
representation of reward was observed by Leon and Shadlen, and
the period whose activity predicts an FEF neuron’s ability to dis-
tinguish targets from distractors (Armstrong et al., 2009). This
pattern of reward modulation contrasts starkly with the response
properties of the DA neurons projecting to PFC, again empha-
sizing the role of DA-ergic activity as a modulator rather than a
simple driver or inhibitor of prefrontal activity.
Spatially-specific representation of reward values in the FEF
and rich DA-ergic inputs to this area raise the hypothesis that FEF
DA could serve as a mechanism for reward-dependent selection
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of visual targets. Indeed, Soltani et al. pursued this idea and tested
the behavioral effects of perturbing DA-ergic activity within the
FEF of monkeys performing a saccadic choice task and simu-
lated the effects using a biologically-plausible cortical network
(Soltani et al., 2013). They found that manipulation of FEF activ-
ity either by blocking D1Rs or by stimulating D2Rs increased
the tendency to choose targets in the RF of the affected site.
These effects of DA manipulation could be described purely in
terms of motor biases; however, DA manipulation also altered
the influence of choice history, and hence reward history, on
subsequent target choices. The effects of choice history were
also differently altered by the two DA receptors: D1R manipu-
lation decreased the tendency to repeat choices on subsequent
trials, whereas the D2R manipulation increased that tendency.
This altered impact of choice history indicates that manipulat-
ing FEF DA influences the value of saccadic targets based on
prior reward experience. The network simulation results sug-
gest that D1Rs influence target selection mainly through their
effects on the strength of inputs to the FEF and on recurrent
connectivity, whereas D2Rs influence the excitability of FEF out-
put neurons. Altogether, these results reveal dissociable DA-ergic
mechanisms influencing target selection in which D1Rs and
D2Rs differentially alter saccadic target selection by virtue of
their effects in different cortical layers (Noudoost and Moore,
2011c). The network model revealed that DA-ergic modula-
tion of the afferents to the FEF could alter reward-dependent
choice. Based on this model one might predict, for example, that
after blocking D1Rs within the FEF, the form and time con-
stant of reward integration would be altered such that the impact
of previous rewards on current choices could be increased or
decreased.
DA is a neuromodulator known to play a crucial role in
reward-dependent behavior. Prefrontal neurons, which receive
rich DA-ergic input from areas representing expected rewards,
play a pivotal role in top-down modulation of cortical activ-
ity. Prefrontal DA (Noudoost and Moore, 2011b) and reward
(Staˇnis¸or et al., 2013) can both modulate representation of targets
within visual areas, mimicking some of the signatures of top-
down visual attention. The questions of whether manipulation of
PFCDA changes reward-dependent behavior, the degree to which
signatures of attention and reward expectation in visual areas are
dissociable, and whether DA-mediated PFC activity is the link for
established behavioral interactions between attention and reward,
remain to be answered.
NOREPINEPHRINE
DA is not the only neuromodulator whose levels are critical for
prefrontal function during cognitive tasks: NE also appears to
be crucial to normal PFC activity. The PFC receives NE input
from the locus coeruleus (Porrino and Goldman-Rakic, 1982;
Levitt et al., 1984). The tonic firing of locus coeruleus NE neu-
rons reflects arousal state, with low rates during slow wave sleep
or drowsiness, moderate rates during waking, and high rates
in response to acute stress. They also display phasic firing in
response to behaviorally relevant stimuli during normal wak-
ing, but this phasic firing can extend to irrelevant distractors
during fatigue or stress (Aston-Jones et al., 1999). Like the DA
projections described above, NE inputs to PFC show a bilami-
nar targeting pattern (Morrison et al., 1982; Levitt et al., 1984;
Lewis and Morrison, 1989). NE binds to high affinity alpha-2
adrenoreceptors, and to lower affinity alpha-1 and beta recep-
tors (Molinoff, 1984). Alpha-2 receptors are found on dendritic
spines in the superficial layers of PFC; although they can func-
tion both pre- and post-synaptically, their postsynaptic activity
appears to underlie the benefits of alpha-2A agonists on work-
ing memory and other cognitive tasks (Arnsten and Cai, 1993;
Wang et al., 2007). Like dopamine, there appears to be an optimal,
intermediate level of NE signaling in PFC. The higher levels of NE
associated with stress may impair PFC function through actions
at the lower affinity alpha-1 receptors in the superficial layers
(Arnsten et al., 1999; Birnbaum et al., 1999; Mao et al., 1999), and
beta receptors localized on dendritic spines in the intermediate
layers (Aoki et al., 1998; Ramos et al., 2005). Intracellularly, the
actions of D1 (Vijayraghavan et al., 2007), alpha-2A (Wang et al.,
2007), and beta1 receptors may converge on the cAMP signaling
pathway (Gamo and Arnsten, 2011). Studies of the contributions
of prefrontal NE to cognitive function led to the development
of alpha-2A agonist guanfacine as a treatment for ADHD (Hunt
et al., 1995; Taylor and Russo, 2001; Biederman et al., 2008; Gamo
and Arnsten, 2011).
HUMAN STUDIES OF PFC CATECHOLAMINES IN NORMAL
AND ABNORMAL COGNITIVE FUNCTION
One of the reasons for focusing on prefrontal catecholamines—
as opposed to, for example, prefrontal N-methyl-D-aspartate
receptor (NMDA) or gamma-Aminobutyric acid (GABA) signal-
ing, the proper functioning of which are certainly also vital to
working memory and other prefrontal functions—is that these
systems appear to be implicated in multiple disorders involving
prefrontal dysfunction. Here we briefly canvas the literature link-
ing prefrontal catecholamines to Parkinson’s, schizophrenia, and
ADHD, before turning to studies of their contribution to normal
cognition in humans.
The loss of DA neurons in Parkinson’s disease produces cog-
nitive deficits in addition to the more outwardly apparent motor
symptoms (Lees and Smith, 1983; Taylor et al., 1986; Morris et al.,
1988; Owen et al., 1992, 1993; Postle et al., 1997). It seems likely
that at least some of these cognitive effects are directly due to a
loss of DA-ergic input to PFC, and can thus provide insight into
the normal contribution of DA to these functions. Accordingly,
multiple studies use the withdrawal of L-dopa or other dopamin-
ergic medications in Parkinson’s patients to evaluate the effect
of reduced DA signaling on various cognitive tasks (Table 2).
Results generally indicate impaired spatial working memory in
the absence of sufficient DA (Lange et al., 1992; Mattay et al.,
2002). They also confirm findings suggesting that increased pre-
frontal activity, measured with fMRI or blood flow, may reflect
less efficient processing in these tasks, showing greater dlPFC
activation in the hypo-DA-ergic state (Cools et al., 2002), and a
correlation between increases in PFC activity and error rates on
the working memory task (Mattay et al., 2002). Interestingly, in
early Parkinson’s disease patients DA loss is more pronounced
in specific anatomical regions, with dramatic DA depletion in
the putamen and dorsal caudate, while DA levels in the ventral
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striatum are relatively spared (Kish et al., 1988; Agid et al., 1993).
These regions of the basal ganglia also differ in their prefrontal
connectivity, the dorsal regions forming a circuit with dlPFC
while the ventral striatum is connected to orbitofrontal cortex
(Alexander et al., 1986). The consequences of this segregation and
differential susceptibility to Parkinson’s-induced DA losses can be
seen in the effect of medication withdrawal on two tasks selected
to differentially engage the dlPFC and the orbitofrontal cortex
(Dias et al., 1996; Cools et al., 2001). Performance on task-set
switching, which is thought to depend on dlPFC and parietal cir-
cuits, was impaired following medication withdrawal; in contrast,
patients’ performance on a reversal learning which depends upon
orbitofrontal cortex actually improved when off of medication.
This reinforces the notion of an optimal level of DA signaling:
when disease-induced DA depletion affects circuits to different
degrees, medication that increases DA globally and optimizes the
level in one circuit may produce above-optimal levels in other
areas, with corresponding behavioral deficits.
DA is also implicated in the etiology of schizophrenia (origins
of this idea reviewed in Baumeister and Francis, 2002). Although
the “dopamine hypothesis” of schizophrenia has existed for
decades, development of theoretical frameworks to link the phar-
macological and neurobiological findings to the phenomenology
of the disorder is ongoing, for example the aberrant salience the-
ory of psychosis (Kapur, 2003; Kapur et al., 2005). Clinically
effective antipsychotics appear to primarily target the D2 recep-
tor (Seeman and Lee, 1975), and hyperstimulation of subcortical
D2Rs is still considered a likely cause of the positive symptoms of
the disorder; in contrast, a cortical, and specifically prefrontal, DA
deficit may contribute to the cognitive symptoms (Abi-Dargham,
2004; Guillin et al., 2007). Associations have been found between
schizophrenia and genetic variations in DA receptors (Glatt et al.,
2003; Jönsson et al., 2004), and the COMT gene discussed
below (Egan et al., 2001, reviewed in Harrison and Weinberger,
2005). COMT genotype has also been associated with the abil-
ity of antipsychotics to improve working memory performance
(Weickert et al., 2004). (However, DA is not the only neurochem-
ical system genetically linked to schizophrenia—see Mowry and
Gratten, 2013). Schizophrenic patients display deficits in work-
ing memory tasks (Park and Holzman, 1992; Fleming et al., 1995;
Morice and Delahunty, 1996; Keefe et al., 1997), and neurocogni-
tive deficits have been shown to predict clinical outcomes (Green,
1996). Patients also show abnormal, typically excessive, PFC acti-
vation during these tasks (Manoach et al., 1999; Callicott, 2000;
Barch et al., 2001; Perlstein et al., 2001). The laminar distribu-
tion of DA-ergic innervation of PFC appears altered (Akil et al.,
1999), and there is some evidence for changes in prefrontal D1R
density (Abi-Dargham et al., 2002, 2012)—although the absence
of such effects in postmortem studies may indicate that expres-
sion levels are normalized by medication (Laruelle et al., 1990;
Meador-Woodruff et al., 1997).
ADHD is one of the most common psychiatric disorders,
affecting ∼3–7% of the US population. Clinically, ADHD
is characterized by inattention, impulsivity, and hyperactivity
(American Psychiatric Association, 2013). In laboratory settings,
ADHD patients’ inattention and impulsivity lead to deficits in
tasks measuring spatial attention (Friedman-Hill et al., 2010),
working memory (Alderson et al., 2013), and oculomotor
response inhibition (Rommelse et al., 2008; Goto et al., 2010).
These cognitive tasks have long been linked to prefrontal func-
tion (D’Esposito and Postle, 1999; Miller, 2000). Given this link,
it is unsurprising that patients with ADHD show structural and
functional differences in prefrontal size, projection strength, rest-
ing connectivity, and activity during cognitive tasks (Seidman
et al., 2005; Arnsten, 2006; Kieling et al., 2008). Several lines
of evidence more specifically implicate prefrontal catecholamine
function as an underlying cause and potential therapeutic tar-
get. Genetic linkage studies confirm potential contributions of
both DA and NE to the disorder (reviewed in Gizer et al.,
2009). Associated genes include DA receptors D1, D4, and D5
(Sunohara et al., 2000; Tahir et al., 2000; Kustanovich et al.,
2004; Bobb et al., 2005; Mill et al., 2006; Wu et al., 2012),
the DA transporter (DAT) (Durston et al., 2005; Mill et al.,
2006), the NE transporter, the NE alpha-2A receptor (Xu et al.,
2001; Roman et al., 2003), and DA beta-hydroxylase, an enzyme
which coverts DA to NE (Daly et al., 1999; Roman et al.,
2002; Kopecková et al., 2006). Many of the medications cur-
rently prescribed to treat ADHD alter catecholamine transmission
(Arnsten, 2009). Stimulants such as amphetamine, lisdexam-
phetamine, and methylphenidrate block both DA and NE trans-
porters. In rats, methylphenidrate (Ritalin®) has been shown to
increase DA and NE release, particularly in the PFC (Berridge
et al., 2006), and improve performance on a delayed alternation
task used to assess prefrontal function in rodents. These per-
formance benefits were blocked by co-administration of either
an alpha-2A or D1R antagonist, neither of which impaired per-
formance in isolation, suggesting that both DA-ergic and nora-
drenergic signaling contribute to the methylphenidate’s cognitive
effects (Arnsten and Dudley, 2005). Atomoxetine blocks the NE
transporter, producing increases in both NE and DA in the PFC
(Bymaster et al., 2002), while guanfacine is an alpha-2A receptor
agonist.
Numerous studies have examined dopamine’s contribution
to cognitive performance by administering various DA agonists
or antagonists to healthy volunteers (see Table 2). Unfortunately
there is no D1R-selective drug available for use in humans; D1R
effects have had to be inferred by comparing the effects of mixed
agonists to those of D2R selective agents. A number of studies
have reported the ability of DA-ergic drugs to alter performance
on spatial working memory or delayed response tasks, although
the studies’ findings differ with respect to the relative contribu-
tion of D1Rs and D2Rs (Luciana et al., 1998; Müller et al., 1998)
and whether the effects are limited to spatial working memory or
apply to a broader range of memory and attention tasks (Luciana
et al., 1998; Kimberg and D’Esposito, 2003). Some of this vari-
ability is probably attributable to an interaction between drug
action and subjects’ baseline DA-ergic tone (see discussion of the
“inverted-U” action of DA above). Indeed, the action of these
drugs in healthy volunteers has been shown to depend on their
baseline working memory capacity (Kimberg and D’Esposito,
2003; Mattay et al., 2003). It may even depend on the subject’s
recent behavior: training on a working memory task, half an
hour a day for 5 weeks, is sufficient to improve capacity measure-
ments and decrease prefrontal D1R binding potential, suggesting
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Table 2 | Studies examining the contribution of prefrontal catecholamines to the behavioral and neural correlates of working memory in
human subjects.
Study Studied agent, gene, or intervention Finding
P
ha
rm
ac
ol
og
ic
al
m
an
ip
ul
at
io
n
Kimberg et al., 1997 Bromocriptine D2R agonist improved WM performance for subjects
with low baseline WM; impaired performance for
subjects with high baseline WM
Kimberg and D’Esposito, 2003 Peroglide Mixed D1R/D2R agonist improved delayed response
performance for both spatial and object WM in high
baseline WM subjects; detrimental in low WM subjects
Luciana et al., 1992 Bromocriptine D2R agonist improved spatial WM performance
Luciana et al., 1998 Bromocriptine, Haloperidol D2R agonist improved spatial, but not non-spatial, WM;
impaired by non-specific DA agonist
Mehta et al., 2001 Bromocriptine D2R agonist improved spatial WM (impaired reversal
learning)
Mehta et al., 1999 Sulpiride D2R antagonist impaired spatial WM performance
Mehta et al., 2004 Sulpiride D2R antagonist impaired spatial delayed response;
interaction with distractor type and baseline WM
Mehta et al., 2000 Methylphenidate Spatial WM benefits of methylphenidate greater for
low-baseline subjects; drug reduced rCBF in dlPFC
during WM task
Elliott et al., 1997 Methylphenidate Methylphenidate improved spatial WM if taken before
task, but impaired already established behavior
Müller et al., 1998 Peroglide, Bromocriptine Mixed D1R/D2R agonist, but not specific D2R agonist,
improved performance on “visuospatial delayed
matching task” at 16 s delays
Gibbs and D’Esposito, 2005 Bromocriptine D2R agonist improved verbal WM performance, more
pronounced for lower baseline WM subjects;
correlation between PFC activity and reaction time
after drug administration (lower PFC activity, faster RT)
Mattay et al., 2000 Dextroamphetamine Improved WM performance in low-baseline individuals
(3-back task); impaired performance high-baseline
subjects; increased rPFC activity, inversely correlated
with change in performance
Fischer et al., 2010 SCH23390 D1R antagonist reduced spatial WM performance and
load-sensitive frontoparietal activity in young adults,
similar to older subjects
Jäkälä et al., 1999 Guanfacine, Clonidine Guanfacine improved while clonidine dose-dependently
impaired spatial WM
P
ET
McNab et al., 2009 D1 and D2 PET WM training improves capacity and decreases
prefrontal D1 binding potential (PET); no effect on D2
BP
Aalto et al., 2005 D2 PET Reduced D2R availability in vlPFC (presumably
reflecting DA release in vlPFC) during WM compared to
sustained attention (PET)
G
en
et
ic
po
ly
m
or
ph
is
m
s
Gordon et al., 2013 DAT1 Heterozygotes had stronger caudate-dlPFC and
striatum-vlPFC connectivity than homozygotes;
caudate connectivity strength predicted n-back WM
performance
Liu et al., 2010 COMT Val homozygotes had reduced “default network” PFC
connectivity
Frank et al., 2007 COMT, DRD2, DARPP-32 Met-allele associated with greater flexibility after a
single negative feedback event
Tian et al., 2013 COMT and DRD2 Interactions between COMT and DRD2 genotype
effects on functional connectivity
Meyer-Lindenberg et al., 2005 COMT Brain stem DA synthesis positively correlated with
dlPFC rCBF for heterozygotes, but negatively
correlated for met-homozygotes
(Continued)
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Table 2 | Continued
Study Studied agent, gene, or intervention Finding
Egan et al., 2001 COMT Activity in PFC during n-back task varies with COMT
phenotype; association between Val allele and
schizophrenia
Mattay et al., 2003 COMT Amphetamine improves 3-back performance and
reduces PFC activity in val-val subjects; impairs
performance and increases PFC activity in met-met
subjects
Goldberg et al., 2003 COMT Relationship between COMT genotype and n-back
performance
Bertolino et al., 2006; Caldú et al., 2007 COMT, DAT COMT and DAT genotype have additive effects on PFC
activity during WM
Zilles et al., 2012 COMT, DAT, 5-HTT DAT, but not COMT, genotype, associated with
differences in spatial WM
Zhang et al., 2007 DRD2 DRD2 intron SNP associated with changes in splicing,
WM perf, and PFC activity
Pa
rk
in
so
n’
s
Lange et al., 1992 L-dopa withdrawal Impaired spatial WM
Cools et al., 2001 Medication withdrawal Medication appears to benefit
prefrontal-parietal-caudate function (task switching),
which is affected by DA loss in PD, but impair
probabilistic reversal learning (orbitofrontal-striatal, DA
levels less affected by PD)
Cools et al., 2002 L-dopa withdrawal L-dopa decreases dlPFC blood flow during spatial WM
Mattay et al., 2002 Timing relative to dopamimetic treatment Increased PFC activity during WM task in
hypodopaminergic state, positive correlation between
increase in activity and errors
Cools et al., 2010 Medication withdrawal Reduced distractability in PD patients off meds
Studies are grouped based on methodology: drug administration, PET, effects of genetic polymorphisms, and medication withdrawal in Parkinson’s patients.
Abbreviations and drug actions: DA, dopamine; bromocriptine, a D2 agonist; pergolide, an agonist for both D1 and D2 receptors; haloperidol, non-specific DA
agonist; methylphenidate, amphetamine, and dextroamphetamine: stimulants producing an increase in PFC DA and NE release; sulpiride, D2 antagonist; guan-
facine, alpha-2A agonist; clonidine, alpha-2 agonist; SCH23390, D1 receptor antagonist; DAT1, dopamine transporter gene; COMT, catechol-O-methyltransferase
gene; 5-HTT, serotonin transporter gene; DARPP-32, dopamine- and cAMP-regulated neuronal phosphoprotein gene; DRD2, dopamine receptor D2 gene; WM,
working memory; PET, positron emission tomography; dlPFC, dorsolateral prefrontal cortex.
DA receptor expression may be modulated by the demands of
habitual tasks (McNab et al., 2009).
Genetic polymorphisms related to DA processing or signaling
have also been linked to cognitive phenotypes, in both neu-
rotypical and patient populations. One of the most extensively
studied is a polymorphism in the catechol-O-methyltransferase
(COMT) gene. COMT is an enzyme that breaks down DA fol-
lowing synaptic release; its activity is especially important for
determining DA levels in the PFC, which has comparatively few
DATs (Gogos et al., 1998). A common polymorphism produc-
ing a valine-to-methionine substitution alters enzyme activity:
the Val-allele has higher enzymatic activity, presumably reduc-
ing prefrontal DA levels, while the Met-allele has lower activity,
theoretically resulting in higher basal DA (Chen et al., 2004);
however these presumed effects of COMT genotype on basal
PFC DA levels have never been directly verified in humans.
It should also be noted that the effects of many DA-related
polymorphisms on working memory may be mediated by the
striatum in addition to the PFC (Cools et al., 2008). Met-allele
homozygotes show lower prefrontal activity during an n-back
working memory task than heterozygotes, who in turn have
lower prefrontal activation than Val-allele homozygotes (Egan
et al., 2001). Amphetamine, which like other stimulants causes
release of DA and NE in PFC (Kuczenski and Segal, 1992;
Moghaddam et al., 1993; Berridge et al., 2006; Narendran et al.,
2014), reduces prefrontal activity during the 3-back task in Val
homozygotes, while increasing prefrontal activity and impairing
performance for Met homozygotes on the same task (Mattay
et al., 2003). These results are consistent with an inverted-U rela-
tionship between prefrontal DA levels and function, where Val
homozygotes have slightly sub-optimal basal DA levels due to
their increased enzymatic breakdown of DA, while Met homozy-
gotes have higher basal DA levels, such that the additional
DA release following amphetamine administration is detrimen-
tal to PFC function. Interestingly, Val-allele homozygotes show
more perseverative errors on the Wisconsin card-sorting task,
but no overall differences in working memory performance or
other cognitive measures (Egan et al., 2001; Mattay et al., 2003;
Zilles et al., 2012); this absence of baseline differences in work-
ing memory based on COMT genotype suggests compensatory
Frontiers in Neural Circuits www.frontiersin.org April 2014 | Volume 8 | Article 33 | 12
Clark and Noudoost Prefrontal catecholamines and cognitive functions
changes in other aspects of DA signaling (although see Goldberg
et al., 2003). The effects of COMT genotype on prefrontal
activity during working memory have been shown to inter-
act additively with another polymorphism, a variable number
tandem repeat polymorphisms identified in the 3′ untranslated
region of the DAT gene (Bertolino et al., 2006; Caldú et al.,
2007).
Performance in attention and working memory tasks is
impaired in ADHD, Parkinson’s disease, and schizophrenia,
as well as under stress or in normal aging. Considering the
evidence for a contribution of prefrontal catecholamines to
these cognitive functions, imbalance in the prefrontal level
of these neuromodulators has long been a suspected cause
of the cognitive impairments observed in these disorders.
More recently, genetic association studies have demonstrated
links between prefrontal catecholamines and the etiology of
these diseases, as well as how patients respond to treatment.
Despite numerous studies examining the link between pre-
frontal DA or NE and cognitive function in these disorders,
we are still far from treatments that fully restore cognitive
function. This gap may be partly due to individual variation
in the underlying pathology, but also partly as a result of
our own incomplete understanding of the neural mechanisms
underlying normal cognitive function. Even in cases where the
mechanisms are well understood, clinically we lack the means
to target specific anatomical or chemical subsets of neurons.
However, basic research on the mechanisms of prefrontal func-
tion has produced some therapeutic advances, e.g., the intro-
duction of guanfacine for the treatment of ADHD patients,
and a more complete understanding of how prefrontal cate-
cholamine signaling underlies cognition may produce further
clinical applications.
CONCLUSIONS AND FUTURE DIRECTIONS
The link between prefrontal catecholamines and cognitive deficits
in multiple neurological disorders makes understanding their
role in prefrontal function particularly critical. While much
progress has been made in elucidating the role of prefrontal
catecholamines’ role in cognitive function, crucial questions
still remain. Is the effect of prefrontal DA mediated entirely
via reward expectation, or do basal PFC DA levels modu-
late working memory and attention performance in a man-
ner dissociable from upcoming rewards? Do PFC DA levels
fluctuate significantly over the course of attention and work-
ing memory tasks, and do these fast changes in DA signaling
contribute to behavioral performance? Although the true “neu-
ral mechanism” of working memory maintenance or covert
attentional deployment is the pattern of task-related neural
activity, driven by spatially tuned glutamatergic and GABA-
ergic responses, these population dynamics are enabled by
appropriate DA and NE “tone” within these prefrontal cir-
cuits; whether more temporally or spatially localized changes
in catecholamine signaling also contribute to task performance
(Chadderdon and Sporns, 2006) remains uncertain. More reli-
able, temporally precise and continuous measures of local DA
levels would be an important first step in addressing these
questions.
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